This year’s program focused on research that has direct patient impact and many of the challenges facing new materials in garnering regulatory approval for clinical use. It also included discussions on many of the issues facing the biomaterials community including COVID-related adjustments to education, and creating a more equitable environment in the biomaterials community and the STEM fields in general. We thank all of our attendees and sponsors for attending our first-ever Virtual Annual Meeting!